J0681 – Injection, ceftobiprole medocaril sodium, 3 mg
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ0681
- Long description
- Injection, ceftobiprole medocaril sodium, 3 mg
- Short description
- Inj ceftobipole medocarl 3mg
- Pricing indicator
51Drugs- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
O1EOther drugs- ASC
- Approved for ambulatory surgical centers
- Added
- October 1, 2025
- Last change
- October 1, 2025 – No change
Frequently asked questions
What is HCPCS code J0681?
J0681 is a HCPCS Level II code for injection, ceftobiprole medocaril sodium, 3 mg.
Does Medicare cover J0681?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J0651 – Injection, levothyroxine sodium (fresenius kabi), not therapeutically equivalent to j0650, 10 mcg
- J0652 – Injection, levothyroxine sodium (hikma), not therapeutically equivalent to j0650, 10 mcg
- J0654 – Injection, liothyronine, 1 mcg
- J0665 – Injection, bupivicaine, not otherwise specified, 0.5 mg
- J0666 – Injection, bupivacaine liposome, 1 mg
- J0668 – Instillation, bupivacaine and meloxicam, 1 mg/0.03 mg
- J0670 – Injection, mepivacaine hydrochloride, per 10 ml
- J0675 – Injection, carboprost tromethamine, 0.1 mg
- J0687 – Injection, cefazolin sodium (wg critical care), not therapeutically equivalent to j0690, 500 mg
- J0688 – Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg
- J0689 – Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg
- J0690 – Injection, cefazolin sodium, 500 mg
- J0691 – Injection, lefamulin, 1 mg
- J0692 – Injection, cefepime hydrochloride, 500 mg
- J0693 – Injection, cefiderocol, 5 mg
- J0694 – Injection, cefoxitin sodium, 1 gm
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.